tiprankstipranks
Gilead Sciences (GILD)
NASDAQ:GILD
US Market
GILD
Gilead Sciences
RESEARCH TOOLSreports

Gilead Sciences (GILD) Stock News & Sentiment

13,826 Followers
Balancing Strategic Oncology Expansion and Execution Risk: Why Gilead’s Tubulis Deal Supports a Hold Rating
Premium
Ratings
Balancing Strategic Oncology Expansion and Execution Risk: Why Gilead’s Tubulis Deal Supports a Hold Rating
1d ago
GILD
Gilead Sciences: Strategic Oncology Expansion and Undervalued Growth Opportunity Driving Buy Rating
Premium
Ratings
Gilead Sciences: Strategic Oncology Expansion and Undervalued Growth Opportunity Driving Buy Rating
1d ago
GILD
Gilead’s Tubulis Acquisition: Building an ADC Oncology Franchise and Enhancing Risk‑Reward for GILD Shares
Premium
Ratings
Gilead’s Tubulis Acquisition: Building an ADC Oncology Franchise and Enhancing Risk‑Reward for GILD Shares
1d ago
GILD
Anthropic Finalizes $400 Million Takeover of AI Startup Coefficient Bio
Premium
Market News
Anthropic Finalizes $400 Million Takeover of AI Startup Coefficient Bio
6d ago
NVO
SNY
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
17d ago
GSK
GILD
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
Premium
Ratings
Buy Rating on Gilead Driven by HIV Franchise Momentum and Upside from Yeztugo and Biktarvy
17d ago
GILD
Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors
Premium
Company Announcements
Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors
20d ago
GILD
More GILD News >

GILD News on the Web

Tempus AI announce strategic collaboration with Gilead
TipRanks News
Bullish
Tempus AI Expands Collaboration With Gilead Sciences To Maximize Insights In Oncology Pipeline
rttnews
Bullish
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Zacks
Neutral
Kymera Therapeutics announces Gilead option exercise to license KT-200
TipRanks News
Bullish
Gilead Sciences (GILD) Advances But Underperforms Market: Key Facts
Zacks
Neutral
Gilead Agrees $5 Billion Tubulis Acquisition To Expand Cancer Drug Pipeline
GuruFocus News
Neutral
Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report?
Zacks
Neutral
Gilead price target raised to $155 from $152 at Truist
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
GILD
Sector Average
Media Buzz
This Week29 articles
Weekly Average19.5 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GILD’s Media Buzz Sentiment?
29 articles about GILD were published this week. In an average week, 19.5 articles are published.
    What is GILD’s weekly average amount of articles?
    In an average week, 19.5 articles about GILD are published.
      What is GILD’s News Sentiment?
      100% of articles about GILD were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        OWLTOwlet
        STAAStaar Surgical
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week